Need professional-grade analysis? Visit stockanalysis.com
$468.51M
N/A
N/A
N/A
Upstream Bio, Inc. (UPB) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $9.26, down 7.31% from the previous close.
Over the past year, UPB has traded between a low of $7.36 and a high of $32.60. The stock has gained 5.1% over this period. It is currently 71.6% below its 52-week high.
Upstream Bio, Inc. has a market capitalization of $468.51M.
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 clinical development for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps, and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.
Side-by-side comparison against top Healthcare peers.